Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001839882-26-028751 <b>Size:</b> 238 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001839882-26-028750 <b>Size:</b> 657 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001839882-26-028748 <b>Size:</b> 244 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001839882-26-028749 <b>Size:</b> 696 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001918704-26-016240 <b>Size:</b> 936 KB

MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial

MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial

SEALSQ’s CEO Carlos Moreira to Lead Quantum Semiconductor Discussions at GSA European Executive Forum in Munich

JFrog and Anthropic Bring Enterprise-Grade Software Supply Chain Governance and Security to Claude Code

NextNRG’s EzShop, Powered by Gopuff, Goes Live in Florida

Amazon Names Kin by Tayari Jones the No. 1 Book of 2026 So Far

Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.

indie Launches Edge AI SoC to Power Smarter Perception Systems for Automotive and Humanoids

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001918704-26-016239 <b>Size:</b> 728 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001839882-26-028747 <b>Size:</b> 377 KB